Sourav Kundu - 31 Jan 2022 Form 4 Insider Report for NextCure, Inc. (NXTC)

Role
Sr VP, Dev. & Mfg.
Signature
/s/ Steven P. Cobourn, as attorney-in-fact for Sourav K. Kundu
Issuer symbol
NXTC
Transactions as of
31 Jan 2022
Net transactions value
$0
Form type
4
Filing time
02 Feb 2022, 15:19:24 UTC
Previous filing
19 Jul 2021
Next filing
01 Mar 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NXTC Employee Stock Option (Right to Buy) Award $0 +58,700 $0.000000 58,700 31 Jan 2022 Common Stock 58,700 $5.57 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One fourth of the option vests on January 31, 2023. The remainder vests in 36 monthly installments beginning on February 28, 2023.